Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.welcuredrugs.com | |
Market Cap | 5.59 Cr. | |
Enterprise Value(EV) | 5.59 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.03 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 159.83 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 70.99 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 1.08 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 3.84 | Calculated using Price: 4.14 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.35 Cr. | 13,512,100 Shares |
FaceValue | 10 | |
About Welcure Drugs & Pharmaceuticals Ltd. | ||
Welcure Drugs & Pharmaceuticals Ltd. (WDPL) was incorporated as a Public Limited Company under the Companies Act, 1956 on 4th June, 1992 and obtained the certificate of commencement of business on 19th June 1992. |
1 Day |
|
+5.08% |
1 Week |
|
+2.22% |
1 Month |
|
+5.61% |
3 Month |
|
+6.43% |
6 Month |
|
+4.28% |
1 Year |
|
-14.29% |
2 Year |
|
-50.83% |
5 Year |
|
+613.79% |
10 Year |
|
+354.95% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 108.61 | -65.80 | 17.83 | -49.46 | 131.74 | 29.03 | 12.65 | |||
Return on Capital Employed (%) | 108.91 | -65.46 | 18.22 | -48.94 | 131.94 | 29.12 | 12.67 | |||
Return on Assets (%) | 10.40 | 227.41 | 94.50 | -58.62 | 14.57 | -34.54 | 112.99 | 27.77 | 12.51 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | |
Non Curr. Liab. | |||||||||||
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | ||||||
Minority Int. | |||||||||||
Equity & Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | |
Non Curr. Assets | 0 | 2 | 1 | ||||||||
Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Other Income | 0 | 0 | 0 | ||||||||
Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Interest | |||||||||||
Depreciation | 0 | ||||||||||
Taxation | |||||||||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Cash Fr. Inv. | 0 | 0 | 1 | ||||||||
Cash Fr. Finan. | -1 | ||||||||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Thu, 16 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication With reference to the above mentioned captioned subject we are hereby submitting the clippings of the English Newspaper "Financial Express" and Hindi newspaper " Jansatta" dated 16th November 2023 in which Un-Audited Financial Results for the quarter and half year ended 30th September 2023 have been published. |
Tue, 14 Nov 2023
Board Meeting Outcome for Outcome Of The Board Meeting Dated 14.11.2023 It is to inform you that following are the outcome of the Board Meeting held today i.e. Tuesday 14th November 2023 at 3:00 PM and concluded at 5.00 PM at the registered office of the Company.1. The Board approved the Un-Audited Financial Results of the Company for the quarter and half year ended 30th September 2023.2. The Board reviewed and took on record the Limited Review Report on the Un-Audited Financial Results of the Company for the quarter and half year ended 30th September 2023.3.The Board considered the change of Address where all or any books of A/c and papers are maintained .4. The Board considered and accepted the Resignation of Mr. Krishnan J Iyer.5. The Board considered and accepted the Resignation of Mr. Faisal S. Shaikh.6. The Board considered the recommendation for appointment of Mr. Suraj Chagan Solanki as Additional Director (Non-Executive and Non- Independent) and Mr. Altaf Hussain Shah as Additional Director (Non-Executive and Independent). |
Tue, 14 Nov 2023
Submission Of Compliance As Per Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 As per Regulation 23(9) SEBI(LODR) Regulation 2015 we are hereby submitting the Disclosure of Related party transactions for the half year ended 30th September 2023. |
Fri, 01 Dec 2023 |
|
|
|
|
|